BOSTON (December 13, 2010) — The following is a statement by Stephen W. Bernstein, Esq., a partner in the law firm of McDermott Will & Emery LLP and international head of the Firm’s Health Industry Practice Group:
“Today's decision needs to be studied carefully and in relationship to all of the components of the recently enacted U.S. health care reform law (PPACA). What is critical, however, and should not be lost in the headlines is that the impetus for the PPACA legislation always was and will continue to be about how employers, consumers, insurance companies and providers must work together to meet the demand for health care services that can be delivered at lower cost with higher quality and with outcomes that can be measured that will then serve as a basis for payment. Regardless of the constitutionality of the insurance mandate, hospitals, physicians and public and private insurers are being forced by the market to develop alternatives to fee-for-service payment models. Patients, employers, and public and private insurers will continue to demand that providers focus on outcomes, cost reduction and quality of care. The underlying market reality will continue to demand that the ‘quality curve bend up and the cost curve down.’”
McDermott Will & Emery has one of the largest and most prestigious health law departments in the world. The Firm was recently ranked “Health Team of the Year” by Chambers USA.
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Düsseldorf, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Rome, San Diego, Silicon Valley and Washington, D.C. Extending our reach to Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.